CYP2A6 Genetic Polymorphism and Nicotine Metabolism of Male Smokers in Indonesia
Downloads
Introduction: One of the main ingredients in cigarettes is nicotine, which has a significant impact on a person's dependence on cigarettes. Nicotine can be detected in a smoker's urine as a sign that his body is processing nicotine. The important enzyme CYP2A6 is involved in nicotine metabolism. This study aimed to determine the relationship between CYP2A6 genetic polymorphisms and nicotine metabolism among male smokers in Indonesia.
Methods: This study included 100 male smokers who met the inclusion criteria in a cross-sectional design using a consecutive sampling between the ages of 20 and 65 years old. Restrictions fragment length polymorphism (RFLP) of the polymerase chain reaction (PCR) was applied to examine the genetic polymorphism of CYP2A6, and nicotine metabolite levels in urine were examined by high-performance liquid chromatography (HPLC) examination.
Results: This study involved one hundred smokers, and 78 tested positive for the CYP2A6 polymorphism. The CYP2A6 genetic polymorphism and nicotine metabolism were not significantly correlated (p-value > 0.05). Allele *1A and genotype 1B/1B were more common in this study population. The majority of study participants had fast metabolic rates.
Conclusion: No correlation was seen between the genetic polymorphisms of CYP2A6 and nicotine metabolism in Indonesian male smokers. Consequently, it is crucial to conduct future research in diverse populations with larger samples.
Liu X, Zhang J, Zhang C, et al. The Inhibition of Cytochrome P450 2A13-Catalyzed NNK Metabolism by NAT, NAB and Nicotine. Toxicol Res (Camb) 2016; 5: 1115–1121. [PubMed]
(WHO) WHO. WHO Global Report on Trends in Prevalence of Tobacco Smoking 2000-2025 - Second Edition. Geneva, https://www.who.int/publications/i/item/9789241514170 (2018).
Hecht SS. Lung Carcinogenesis by Tobacco Smoke. Int J Cancer 2012; 131: 2724–2732. [PubMed]
Holipah H, Sulistomo HW, Maharani A. Tobacco Smoking and Risk of All-Cause Mortality in Indonesia. PLoS One 2020; 15: e0242558. [PubMed]
Astuti PAS, Assunta M, Freeman B. Why is Tobacco Control Progress in Indonesia Stalled? - A Qualitative Analysis of Interviews with Tobacco Control Experts. BMC Public Health 2020; 20: 527. [PubMed]
Al Koudsi N, Hoffmann EB, Assadzadeh A, et al. Hepatic CYP2A6 Levels and Nicotine Metabolism: Impact of Genetic, Physiological, Environmental, and Epigenetic Factors. Eur J Clin Pharmacol 2010; 66: 239–251. [PubMed]
Soeroso N, Zain-Hamid R, Bihar S, et al. Genetic Polymorphism of CYP2A6 and CYP2A13 Genes and Environmental Tobacco Smoke Induced Lung Cancer Risk in Indonesian Female Never Smokers. Open Access Maced J Med Sci 2021; 9: 1219–1225. [Journal]
Bao Z, He X-Y, Ding X, et al. Metabolism of Nicotine and Cotinine by Human Cytochrome P450 2A13. Drug Metab Dispos 2005; 33: 258–261. [PubMed]
Statistics NC for H. Tobacco Statistics. Centers for Disease Control and Prevention (CDC), https://www.cdc.gov/nchs/nhis/tobacco/tobacco_statistics.htm (2017, accessed 4 March 2022).
Nakajima M, Yoshida R, Fukami T, et al. Novel Human CYP2A6 Alleles Confound Gene Deletion Analysis. FEBS Lett 2004; 569: 75–81. [PubMed]
Patramurti C, Martono S, Sugiyanto S, et al. Optimized Method of High Performance Liquid Chromatography using Octyl Silica Fully Endcapped Residual Silanol Column on Separation of Cotinine and 3-Hydroxycotinine in Urine Sample. J Ilmu Kefarmasian Indones; 12, http://jifi.farmasi.univpancasila.ac.id/index.php/jifi/article/view/195 (2014).
Badan Penelitian dan Pengembangan Kesehatan. Laporan Hasil Riset Kesehatan Dasar (RISKESDAS) Nasional 2018. Jakarta, 2018.
Cornelius ME, Loretan CG, Wang TW, et al. Tobacco Product Use among Adults ” United States, 2020. Morbidity and Mortality Weekly Report (MMWR) 2022; 397–405. [PubMed]
Zhu AZX, Binnington MJ, Renner CC, et al. Alaska Native Smokers and Smokeless Tobacco Users with Slower CYP2A6 Activity Have Lower Tobacco Consumption, Lower Tobacco-Specific Nitrosamine Exposure and Lower Tobacco-Specific Nitrosamine Bioactivation. Carcinogenesis 2013; 34: 93–101. [PubMed]
Sanner T, Grimsrud TK. Nicotine: Carcinogenicity and Effects on Response to Cancer Treatment - A Review. Front Oncol 2015; 5: 196. [PubMed]
Jiang J-H, Jia W-H, Chen H-K, et al. Genetic Polymorphisms of CYP2A13 and Its Relationship to Nasopharyngeal Carcinoma in the Cantonese Population. J Transl Med 2004; 2: 24. [PubMed]
Tanner J-A, Novalen M, Jatlow P, et al. Nicotine Metabolite Ratio (3-Hydroxycotinine/Cotinine) in Plasma and Urine by Different Analytical Methods and Laboratories: Implications for Clinical Implementation. Cancer Epidemiol Biomarkers Prev 2015; 24: 1239–1246. [PubMed]
Zhang X, Su T, Zhang Q-Y, et al. Genetic Polymorphisms of the Human CYP2A13 Gene: Identification of Single-Nucleotide Polymorphisms and Functional Characterization of an Arg257Cys Variant. J Pharmacol Exp Ther 2002; 302: 416–423. [PubMed]
Cheng X-Y, Chen G-L, Zhang W-X, et al. Arg257Cys Polymorphism of CYP2A13 in a Chinese Population. Clin Chim Acta 2004; 343: 213–216. [PubMed]
Su T, Bao Z, Zhang QY, et al. Human Cytochrome P450 CYP2A13: Predominant Expression in the Respiratory Tract and Its High Efficiency Metabolic Activation of a Tobacco-Specific Carcinogen, 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone. Cancer Res 2000; 60: 5074–5079. [PubMed]
Mong C, Garon EB, Fuller C, et al. High Prevalence of Lung Cancer in a Surgical Cohort of Lung Cancer Patients a Decade after smoking Cessation. J Cardiothorac Surg 2011; 6: 19. [PubMed]
Nakajima M, Yamamoto T, Kuroiwa Y, et al. Improved Highly Sensitive Method for Determination of Nicotine and Cotinine in Human Plasma by High-Performance Liquid Chromatography. J Chromatogr B Biomed Sci Appl 2000; 742: 211–215. [PubMed]
Yoshida R, Nakajima M, Watanabe Y, et al. Genetic Polymorphisms in Human CYP2A6 Gene Causing Impaired Nicotine Metabolism. Br J Clin Pharmacol 2002; 54: 511–517. [PubMed]
Soeroso NN, Zain-Hamid R, Sinaga B, et al. Genetic Polymorphism of CYP2A6 and Its Relationship with Nicotine Metabolism in Male Bataknese Smokers Suffered from Lung Cancer in Indonesia. Open Access Maced J Med Sci 2018; 6: 1199–1205. [PubMed]
Benowitz NL, Pomerleau OF, Pomerleau CS, et al. Nicotine Metabolite Ratio as a Predictor of Cigarette Consumption. Nicotine Tob Res 2003; 5: 621–624. [PubMed]
Copyright (c) 2024 Chaliza Soliha, Noni Novisari Soeroso, Fannie Rizki Ananda, Rozaimah Zain Hamid, Syamsul Bihar, Darren Wan-Teck Lim
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).
4. The Creative Commons Attribution Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violation.
JR (